The partnership will bring Royal Biologics’ products to more patients in the U.S., including the Fibrinet platelet rich fibrin matrix for spinal fusions and the Maxx-PRP for orthopedics.
The partnership will also seek adoption of the biologics in the VA and department of defense.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
